The Patent Finder

Biotype Diagnostic GmbH

Also on record
Records under this name other than the patents Biotype Diagnostic GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 6 of 6 · Back to Biotype Diagnostic GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,669,573Confirmation test for primary nucleic acid amplification products in a continuous reaction setup and immediate analysis via immunochromatographic methods
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,368,246Quantitative gene expression profiling
Term ended
Term ended Jan 8, 2026 · USPTO record
Term endedTerm ended Jan 8, 2026USPTO record
US 7,081,339Methods for variation detection
Term ended
Term ended Jul 25, 2024 · USPTO record
Term endedTerm ended Jul 25, 2024USPTO record
US 7,445,893Sampling method for amplification reaction analysis
Term ended
Term ended May 24, 2023 · USPTO record
Term endedTerm ended May 24, 2023USPTO record
US 7,674,582Methods for amplification monitoring and gene expression profiling, involving real time amplification reaction sampling
Term ended
Ended no later than Mar 12, 2023 · USPTO record
Term endedEnded no later than Mar 12, 2023USPTO record
US 8,182,995Real time gene expression profiling
Term ended
Ended no later than Mar 12, 2023 · USPTO record
Term endedEnded no later than Mar 12, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited